DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Gerding DN, Kelly CP, Rahav G. et al.
Bezlotoxumab for prevention of recurrent C. difficile infection in patients at increased risk for recurrence.
Clin Infect Dis 2018;
DOI: 10.1093/cid/ciy171.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.